AudioScholar Infectious Disease Weekly

AudioScholar
  • 0.0 (0)
  • Medicine
  • Updated Weekly

Infectious Disease — a weekly podcast briefing of the most significant peer-reviewed infectious disease literature, synthesized from PubMed and delivered as ~10-minute audio. For practicing physicians. Generated by AudioScholar at audioscholar.cc.

Episodes

  1. 11h ago

    This Week in Infectious Disease — Jul 10, 2026

    Welcome to This Week in Infectious Disease. This week we're covering eight notable papers spanning antimicrobial resistance strategies, viral prevention and treatment optimization, and clinical outcomes in vulnerable global populations. Let's dive in… This week's papers: 1. Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open… — Lancet 2026 2. Virologic insights from the phase 3 REDPINE trial: remdesivir in renally impaired and immunocompromised patients with COVID-19. — Antimicrobial agents and chemotherapy 2026 3. The Effect of Prevaccination Analgesics on Influenza Vaccine Immunogenicity and Effectiveness. — The Journal of infectious diseases 2026 4. HIV capsid inhibitors: Mechanisms, resistance, and therapeutic advances. — PLoS pathogens 2026 5. Protective effects of influenza B neuraminidase antibodies against symptomatic influenza virus infection. — The Journal of infectious diseases 2026 6. In-hospital and post-discharge mortality among infants with respiratory syncytial virus in rural Kenya: a 25-year retrospective cohort study. — The Lancet. Global health 2026 7. Safety evaluation of pretomanid, an anti-tuberculosis drug, for the treatment of pregnant and lactating women. — Antimicrobial agents and chemotherapy 2026 8. Mechanisms involved in cefiderocol resistance in French clinical strains. — Antimicrobial agents and chemotherapy 2026 Listen at https://audioscholar.cc/episode/sdbcwsrea9

    15 min

  2. Jul 4

    This Week in Infectious Disease — Jul 3, 2026

    Welcome to This Week in Infectious Disease. This week we are covering ten notable papers spanning three broad themes: optimizing antibiotic selection, dosing, and duration in bacteremia and focal infections; improving screening and diagnostic strateg… This week's papers: 1. Antibiotic Treatment Duration for Uncomplicated Monomicrobial Enterococcal Bloodstream Infection: A Multicenter Target Trial Emulation. — Clinical Infectious Diseases 2026 2. A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-… — The Journal of Antimicrobial Chemotherapy 2026 3. Reconsidering ambiguous language in infectious disease consult recommendations. — Clinical Infectious Diseases 2026 4. Incidence and factors associated with subtherapeutic cefazolin levels among patients with severe infections. — The Journal of Antimicrobial Chemotherapy 2026 5. Phone-based screening versus home-based screening after tuberculosis in India (TB Aftermath): a multicentre, open-label, randomised, controlled, non-inferiorit… — The Lancet. Global Health 2026 6. Defining Success and Failure In Prosthetic Joint Infections: A Meta-epidemiologic Study Toward A Core Outcome Set. — Open Forum Infectious Diseases 2026 7. Vancomycin Penetration into Intra-abdominal Compartments: Site Concentration Disparities and Implications for Dose Optimization in Gram-Positive Infections. — International Journal of Antimicrobial Agents 2026 8. Larger Blood Volume Increases Detection of Fastidious Mycobacteria and Fungi in Blood Culture. — Clinical Infectious Diseases 2026 9. Optimizing Hepatitis C Virus Antibody Testing Strategy and Setting: Results From a Large Real-World Screening Program. — Open Forum Infectious Diseases 2026 10. Expert consensus on case definitions in human loiasis: a Delphi study. — The Lancet. Infectious Diseases 2026 Listen at https://audioscholar.cc/episode/mn2rud2y2n

    14 min

  3. Jun 26

    This Week in Infectious Disease — Jun 25, 2026

    Welcome to This Week in Infectious Disease. This week we're covering 10 notable papers spanning global outbreak modeling and vector dynamics, novel therapeutic strategies for chronic viral and bacterial infections, and emerging diagnostic and environ… This week's papers: 1. Size of the 2026 Ebola outbreak and risk of cross-border spillover from Bundibugyo virus in Ituri Province, DR Congo, and its implications for preparedness: a… — The Lancet. Infectious diseases 2026 2. The origin, history, and resistance architecture of an invasive urban malaria mosquito in Africa. — Science 2026 3. A Streptomyces megacluster encodes synergistic biotin-targeting antibiotics. — Nature 2026 4. Prevalence and epidemiological patterns of Neisseria gonorrhoeae infection in sub-Saharan Africa, 1964-2025: Systematic review, meta-analyses, and meta-regress… — PLoS medicine 2026 5. Klebsiella genus as driver of human disease: from infections to non-communicable disorders. — Nature reviews. Microbiology 2026 6. FDG-PET/CT Demonstrates Superior Detection of Multiorgan Involvement in Paracoccidioidomycosis Compared with Conventional Staging. — Clinical infectious diseases 2026 7. WHO estimates of the global, regional, and national disease burden of nine foodborne chemicals, 2000-21: an updated data synthesis. — The Lancet. Global health 2027 8. Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection. — The New England journal of medicine 2026 9. Effectiveness of the BNT162b2 LP.8.1-adapted SARS-CoV-2 vaccine against COVID-19-associated hospitalisation and death: a Danish nationwide cohort study. — The Lancet. Infectious diseases 2026 10. An anaerobic pathogen rewires host metabolism to fuel oxidative growth in the inflamed gut. — Cell 2026 Listen at https://audioscholar.cc/episode/3pv2rstvvb

    10 min

  4. Jun 19

    This Week in Infectious Disease — Jun 18, 2026

    Welcome to This Week in Infectious Disease. This week we're covering 10 notable papers spanning major clinical trials in bacterial infections, new data on vaccine effectiveness for COVID-19 and Mpox, and a look at the future of antimicrobial discover… This week's papers: 1. An HIV vaccine blueprint. — Science (New York, N.Y.) 2026 2. Neutralising antibody responses to MPXV clades Ia, Ib, and IIb after infection or vaccination: a multicountry observational study. — The Lancet. Infectious diseases 2026 3. Fosfomycin as Oral Transition Therapy Versus Continued Intravenous β-Lactams for Complicated Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-P… — Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026 4. Deep learning-enabled discovery of antibiotics effective against Neisseria gonorrhoeae. — Science translational medicine 2026 5. Engineered antibodies bypass bacterial immune evasion to drive complement-mediated protection against lethal infections. — Science translational medicine 2026 6. Estimated Effectiveness of 2024-2025 COVID-19 Vaccines in Adults. — JAMA internal medicine 2026 7. Analysis of 173,303 exomes and genomes in the Pakistan Genome Resource. — Nature 2026 8. WHO estimates of the global, regional, and national burden of 14 foodborne diarrhoeal enteric hazards, 2000-21: an updated data synthesis. — The Lancet. Global health 2026 9. Identification of host gene transcripts by machine learning and their application to predict outcome in Ebola virus disease. — The Journal of infectious diseases 2026 Listen at https://audioscholar.cc/episode/ahe6d4bghz

    10 min

  5. Jun 12

    This Week in Infectious Disease — Jun 11, 2026

    Welcome to This Week in Infectious Disease. This week we're covering 10 notable papers spanning practical hospital-based infection control, the intricacies of host-virus interactions, and the latest in global health epidemiology and policy. Let's div… This week's papers: 1. Cost-effectiveness of Commercial or Traditional Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection. — Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026 2. SARS-CoV-2 variant booster vaccination and infection alter the breadth of the memory B cell repertoire. — Science translational medicine 2026 3. GPR15-guided CD8T regulatory cells control intestinal inflammation. — Nature 2026 4. Understanding sugar-sweetened beverage tax implementation globally: a 34-year, population-based observational study in 183 countries. — The Lancet. Global health 2026 5. Inclusion of young adolescents in policy development for new tuberculosis vaccines. — The Lancet. Global health 2026 6. Effectiveness of oral care for the prevention of non-ventilator hospital-acquired pneumonia (HAPPEN): a multicentre, stepped-wedge, cluster-randomised trial in… — The Lancet. Infectious diseases 2026 7. Zoster Vaccination and Dementia: Interpreting the Signal and Testing the Mechanisms. — Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026 8. Molecular Epidemiology to Decipher the Transmission Networks of MPOX in an Outbreak Scenario: Applications in Thailand during the 2023 Global Health Emergency. — The Journal of infectious diseases 2026 9. Implementing the commitments of the World Health Assembly kidney health resolution: a key opportunity to improve health for millions. — Lancet (London, England) 2026 10. Systematic discovery of pro- and anti-HIV host factors in primary human CD4+ T cells. — Cell 2026 Listen at https://audioscholar.cc/episode/qynmhj8cvj

    10 min

  6. Jun 6

    This Week in Infectious Disease — Jun 6, 2026

    Welcome to This Week in Infectious Disease. This week we're covering 10 notable papers spanning the global fight against antimicrobial resistance, new insights into host immunology and viral reservoirs, and key updates in prevention and therapeutics.… This week's papers: 1. Global, regional, and national impact of the Expanded Programme on Immunization against 14 pathogens from 1974 to 2024: an economic evaluation. — The Lancet. Global health 2026 2. Plasma signals of lung tumor promotion for molecular cancer prevention. — Cell 2026 3. Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial. — JAMA 2026 4. A natural depsipeptide antibiotic binds the E-site of the bacterial ribosome. — Nature 2026 5. Kidney Transplantation in Two Highly Sensitized Candidates after CAR T-Cell Therapy. — The New England journal of medicine 2026 6. Intravenous Artesunate in Artemisinin-Resistant Severe Malaria in Uganda. — The New England journal of medicine 2026 7. Sudan Virus Disease in Uganda, 2025. — The New England journal of medicine 2026 8. HIV-1 infection converts CD4T cells to HLA class II-restricted CD8T cells. — Science translational medicine 2026 9. Limitations of Global Surveillance for Neisseria gonorrhoeae Antimicrobial Resistance. — Emerging infectious diseases 2026 10. Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development. — The Lancet. Infectious diseases 2025 Listen at https://audioscholar.cc/episode/wh3r359zad

    9 min

  7. May 28

    This Week in Infectious Disease — May 28, 2026

    Welcome to This Week in Infectious Disease. This week we're covering 10 notable papers spanning diagnostics and stewardship, new therapies for major global infections, and key updates in public health and epidemiology. Let's dive in. [PAUSE] We beg… This week's papers: 1. Clinical Impact and Cost-Effectiveness of Improving Access to Cryptococcal Meningitis Diagnostics and Treatment in Malawi. — Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026 2. Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection. — The New England journal of medicine 2026 3. Sustained and indirect effects of PCV10 reduced-dose schedules on pneumococcal carriage in Viet Nam: a long-term follow-up of a cluster-randomised controlled t… — The Lancet. Infectious diseases 2026 4. Differences in tuberculosis prevalence by sex in low- and middle-income countries over 1993-2025: A systematic review and meta-analysis. — PLoS medicine 2026 5. U = U for all: Advancing equity in HIV prevention. — PLoS medicine 2026 6. Fast Antimicrobial Susceptibility Testing for Gram-Negative Bacteremia: The FAST Randomized Clinical Trial. — JAMA 2026 7. A combined ELISA for infection-induced and vaccine-induced mpox antibodies during the clade Ib outbreak in Rwanda: an observational, cross-sectional, clinical… — The Lancet. Infectious diseases 2026 8. Varicella zoster virus and the central nervous system. — Nature reviews. Microbiology 2026 9. Immediate or high-dose antituberculosis therapy for HIV-related sepsis in Tanzania and Uganda (ATLAS): a phase 3, open-label, randomised, controlled, 2 × 2 fac… — The Lancet. Infectious diseases 2026 10. Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation: r… — The Lancet. Infectious diseases 2025 Listen at https://audioscholar.cc/episode/krynrdthrs

    12 min

  8. May 21

    This Week in Infectious Disease — May 21, 2026

    Welcome to This Week in Infectious Disease. This week we're covering 8 notable papers spanning advances in HIV prevention and management, antimicrobial stewardship in common outpatient infections, and the global landscape of surveillance, new drugs,… This week's papers: 1. Global and regional molecular epidemiology of HIV-1 during 1990-2024: systematic review, global survey, and analysis of prevalence. — The Lancet. Infectious diseases 2026 2. Azithromycin for Preschoolers with Wheezing in the Emergency Department. — The New England journal of medicine 2026 3. Multi-Center Real-World Implementation Outcomes of Lenacapavir for HIV Pre-Exposure Prophylaxis. — Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026 4. Differing Presentations of Excess Visceral Abdominal Fat in People Living With HIV: Two Clinical Cases Highlighting Distinct Therapeutic Pathways With Tesamore… — Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026 5. Quantifying relative health impact across Gavi, the Vaccine Alliance's portfolio in 117 countries at the subregional level: a modelling study. — Lancet (London, England) 2026 6. Efficacy and safety of cefepime-nacubactam and aztreonam-nacubactam compared with imipenem-cilastatin for complicated urinary tract infection or acute uncompli… — Lancet (London, England) 2026 7. Amoxicillin-Clavulanate vs Amoxicillin for Acute Sinusitis in Adults. — JAMA 2026 8. Antiretroviral Activity, Pharmacokinetics, and Safety of MK-8527, an Oral Nucleoside Reverse Transcriptase Translocation Inhibitor, in Adults With HIV-1 Who Ha… — Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026 Listen at https://audioscholar.cc/episode/sut9m3kvcj

    13 min

  9. May 14

    This Week in Infectious Disease — May 14, 2026

    Welcome to This Week in Infectious Disease. This week we're covering 8 notable papers spanning global health prevention, neonatal sepsis, and the evolving landscape of viral infections. Let's dive in. [PAUSE] Our first theme is rethinking preventio… This week's papers: 1. Understanding and exploiting superspreading to disrupt Mycobacterium tuberculosis transmission. — The Lancet. Infectious diseases 2026 2. Post-mortem characterisation of pathogen-specific causes of infection-related deaths in African and south Asian neonates: a prospective, observational, multice… — The Lancet. Infectious diseases 2026 3. Sex-specific presentation, epidemiology, and control of schistosomiasis in women and adolescent girls. — The Lancet. Global health 2026 4. Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts. — The New England journal of medicine 2026 5. Contribution of nosocomial transmission to Klebsiella pneumoniae neonatal sepsis in Africa and South Asia: An observational study of infection clusters inferre… — PLoS medicine 2026 6. Global, regional, and national estimates of tuberculosis incidence averted by eliminating undernutrition in adults: a modelling study. — The Lancet. Global health 2026 7. Impact of introducing RTS,S/AS01malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised… — Lancet (London, England) 2026 8. Respiratory viral infections prime accelerated lung cancer growth. — Cell 2026 Listen at https://audioscholar.cc/episode/eda8zt4yva

    11 min
  • 9 Episodes

About

Infectious Disease — a weekly podcast briefing of the most significant peer-reviewed infectious disease literature, synthesized from PubMed and delivered as ~10-minute audio. For practicing physicians. Generated by AudioScholar at audioscholar.cc.

Information